SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-065293
Filing Date
2023-11-21
Accepted
2023-11-21 06:13:49
Documents
8
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 6-K cntb_6k_20231121-1.htm 6-K 98115
2 EX-99.1 cntb-ex99_1.htm EX-99.1 477300
3 EX-99.2 cntb-ex99_2.htm EX-99.2 42041
4 GRAPHIC img219389868_0.jpg GRAPHIC 134840
5 GRAPHIC img219389868_1.jpg GRAPHIC 149557
6 GRAPHIC img220313389_0.jpg GRAPHIC 9315
7 GRAPHIC img268147174_0.jpg GRAPHIC 12223
8 GRAPHIC img268147174_1.jpg GRAPHIC 8650
  Complete submission text file 0000950170-23-065293.txt   1052445
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 231424447
SIC: 2834 Pharmaceutical Preparations